ask="3.99"
ask_size="2000"
average_daily_volume="224250"
bid="3.00"
bid_size="200"
book_value="0.56"
change="+0.08"
change_from_200_day_moving_average="1.11"
change_from_50_day_moving_average="0.70"
change_from_52_week_high="-0.27"
change_From_52_week_low="1.54"
change_in_percent="+2.27%"
close="3.60"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.31"
ebitda="-5.76M"
eps_estimate_current_year="-0.30"
eps_estimate_next_quarter="-0.21"
eps_estimate_next_year="-0.91"
ex_dividend_date="N/A"
float_shares="16233000"
high="3.61"
high_52_weeks="3.87"
last_trade_date="2/17/2017"
last_trade_price="3.60"
last_trade_size="549"
last_trade_time="4:00pm"
low="3.45"
low_52_weeks="2.06"
market_capitalization="67.27M"
moving_average_200_day="2.49"
moving_average_50_day="2.90"
name="Brainstorm Cell Therapeutics In"
notes="N/A"
one_year_target_price="6.00"
open="3.59"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+44.31%"
percent_change_from_50_day_moving_average="+23.97%"
percent_change_from_52_week_high="-6.98%"
percent_change_from_52_week_low="+74.75%"
previous_close="3.52"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.25"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18687000"
short_ratio="7.59"
stock_exchange="NCM"
symbol="BCLI"
volume="119570"
weeks_range_52="2.06 - 3.87"
